Here’s Why Oppenheimer Sees These 2 Stocks Under $10 Surging Over 200% and Potentially Jumping

Here’s Why Oppenheimer Sees These 2 Stocks Under  Surging Over 200% and Potentially Jumping



The oldest advice in the financial⁣ markets is to buy low and sell high. The trick to winning, however, ⁣is to find the ‌right stocks to buy, and to remember that ‘buy‌ low’ doesn’t‍ always mean these stocks can’t⁣ go lower.

Sometimes the best bargains really do⁤ come in at‌ the lowest prices. There are plenty of stocks under $10 that won’t break your bank and still offer substantial upside ‌potential.‍ How‌ substantial? Well, the analysts at investment banking giant Oppenheimer have pinpointed two ⁤winners among these low-cost stocks, and they see the upside⁣ beginning at 200% or better.

What’s more, after ‍using⁤ TipRanks’ database, we found out that ‌both have scored enough positive reviews from the broader analyst⁢ community to earn a ‘Strong Buy’ consensus rating. Let’s see why‌ these stocks ‌are drawing ⁣plaudits across the ‌board.

Corvus Pharmaceuticals (CRVS)

The first Oppenheimer pick we’re looking at is Corvus, a ⁤clinical-stage biopharmaceutical ‌company‌ focused on cancer…

2023-08-30⁣ 09:01:34
Link from finance.yahoo.com
rnrn

Exit mobile version